Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Visual-ICE Cryoablation System Recalled by Galil Medical, Inc. Due to Visual-ICE utilizing the IceSeed 1.5 and IceRod 1.5...

Date: October 25, 2019
Company: Galil Medical, Inc.
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Galil Medical, Inc. directly.

Affected Products

Visual-ICE Cryoablation System, FPRCH6000. The cryoablation system is a mobile console system intended for cryoablative tissue destruction using a minimally invasive procedure. The system is computer-controlled with a touch screen user interface that allows the user to control and monitor the procedure. The therapy delivered by the system is based on the Joule-Thomson effect displayed by compressed gases. The Visual-ICE System uses high-pressure argon gas that circulates through closed-tip cryoablation needles to induce tissue freezing. Active tissue thawing is achieved by circulating helium gas through the needles or, alternatively , by the use of Galil Medical I-Thaw technology in which a heating element inside the cryoablation needle can be energized to cause thawing.

Quantity: 49 systems

Why Was This Recalled?

Visual-ICE utilizing the IceSeed 1.5 and IceRod 1.5 PLUS cryoablation needles could have issues with the needle clogging and/or inadequate freezing performance.

Where Was This Sold?

This product was distributed to 21 states: AL, AK, AZ, AR, CA, FL, GA, HI, KY, MA, MI, MN, NY, NC, ND, OH, PA, SC, TN, UT, VA

Affected (21 states)Not affected

About Galil Medical, Inc.

Galil Medical, Inc. has 2 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report